Granules India Limited has informed the Exchange regarding a press release dated December 30, 2021, titled "Granules Pharmaceuticals, Inc. receives ANDA approval for Amphetamine Mixed Salts (IR Tablets)".
Press Release Dec 30 2021
Filed with NSE · · 3 pages · English
Watch Granules India's latest callGranules India (NSE:GRANULES) Q2 2027 Earnings Call · Replay · Nov 2Read the transcript of Granules India (NSE:GRANULES) Q2 2027 Earnings CallRelease
Earlier from Granules India
- Press Release Dec 28 2021
- Press Release Sep 13 2021
- Press Release Aug 30 2021
- Press Release Jul 21 2021
- Press Release Feb 24 2021
Later from Granules India
- Press Release Jan 28 2022
- Press Release Jan 31 2022
- Press Release Feb 03 2022
- Press Release Mar 15 2022
- Press Release Mar 18 2022
Follow Granules India into a list and get an email when it puts out news.
Follow Granules India